Essex Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,314
Closed -$1.58M 410
2022
Q4
$1.58M Sell
4,314
-776
-15% -$275K 0.25% 123
2022
Q3
$1.65M Sell
5,090
-1,171
-19% -$371K 0.26% 121
2022
Q2
$2.03M Sell
6,261
-1,787
-22% -$536K 0.33% 92
2022
Q1
$2.31M Sell
8,048
-452
-5% -$116K 0.29% 105
2021
Q4
$2.35M Hold
8,500
0.27% 119
2021
Q3
$1.96M Hold
8,500
0.24% 140
2021
Q2
$1.95M Buy
+8,500
New +$1.71M 0.23% 144
2020
Q3
Sell
-292
Closed -$48K 491
2020
Q2
$48K Hold
292
0.01% 350
2020
Q1
$41K Hold
292
0.01% 337
2019
Q4
$38K Hold
292
﹤0.01% 415
2019
Q3
$33K Hold
292
﹤0.01% 405
2019
Q2
$32K Hold
292
﹤0.01% 414
2019
Q1
$38K Hold
292
0.01% 405
2018
Q4
$34K Buy
+292
New +$32.6K 0.01% 410
2017
Q3
Sell
-10,978
Closed -$903K 372
2017
Q2
$903K Sell
10,978
-6,752
-38% -$551K 0.13% 205
2017
Q1
$1.49M Sell
17,730
-3,646
-17% -$292K 0.23% 120
2016
Q4
$1.57M Sell
21,376
-94,628
-82% -$7.05M 0.26% 104
2016
Q3
$9.31M Buy
116,004
+107,477
+1,260% +$8.6M 1.5% 11
2016
Q2
$672K Hold
8,527
0.11% 201
2016
Q1
$614K Sell
8,527
-1,436
-14% -$109K 0.11% 199
2015
Q4
$839K Buy
+9,963
New +$827K 0.13% 169

Other funds holding LLY

Essex Investment Management's LLY Position: Q1 2023 in Review

Essex Investment Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 4,314 shares — an estimated $1.58M sold.

Essex Investment Management first reported a position in LLY in Q4 2015 and held it in 21 quarters. The position peaked at $9.31M in Q3 2016. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Essex Investment Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Essex Investment Management sold 4,314 Eli Lilly shares in Q1 2023, an estimated $1.58M.
  • Essex Investment Management first reported a position in Eli Lilly in Q4 2015 and held it in 21 quarters.
  • Essex Investment Management's Eli Lilly position peaked at $9.31M in Q3 2016.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Essex Investment Management's 13F filing for Q1 2023, filed 4 May 2023.